Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 | +$549M | |
| 2 | +$467M | |
| 3 | +$441M | |
| 4 |
Broadcom
AVGO
|
+$350M |
| 5 |
CoStar Group
CSGP
|
+$320M |
Top Sells
| 1 | +$1.62B | |
| 2 | +$570M | |
| 3 | +$562M | |
| 4 |
Mastercard
MA
|
+$313M |
| 5 |
Johnson & Johnson
JNJ
|
+$300M |
Sector Composition
| 1 | Technology | 36.59% |
| 2 | Healthcare | 15.91% |
| 3 | Consumer Discretionary | 10.83% |
| 4 | Financials | 10.24% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Liberty Media Series A
FWONA
$21.3B
| $91.9M | 0.05% |
967,291
+5,050
|
|
||
277
IBM
IBM
$290B
| $91.5M | 0.04% |
310,399
+180,012
|
|
||
278
iShares Core S&P 500 ETF
IVV
$733B
| $91M | 0.04% |
146,497
-90,362
|
|
||
279
monday.com
MNDY
$8.38B
| $90.8M | 0.04% |
288,687
+174,043
|
|
||
280
HDFC Bank
HDB
$180B
| $90.5M | 0.04% |
2,361,854
+506,160
|
|
||
281
Dyne Therapeutics
DYN
$2.63B
| $89.9M | 0.04% |
9,437,962
-915,454
|
|
||
282
Trip.com Group
TCOM
$45.8B
| $89.5M | 0.04% |
1,525,592
-831,491
|
|
||
283
Berkshire Hathaway Class B
BRK.B
$1.06T
| $89.3M | 0.04% |
184,102
-4,049
|
|
||
284
HealthEquity
HQY
$7.97B
| $89.3M | 0.04% |
852,595
+7,556
|
|
||
285
Rhythm Pharmaceuticals
RYTM
$6.72B
| $89.3M | 0.04% |
1,411,902
-243,448
|
|
||
286
Edwards Lifesciences
EW
$48.3B
| $89M | 0.04% |
1,137,366
+134,865
|
|
||
287
Roper Technologies
ROP
$47.4B
| $88.7M | 0.04% |
156,536
+6,990
|
|
||
288
Silgan Holdings
SLGN
$4.03B
| $87.3M | 0.04% |
1,611,715
+40,849
|
|
||
289
Welltower
WELL
$134B
| $87.3M | 0.04% |
568,222
-42,280
|
|
||
290
Scholar Rock
SRRK
$4.55B
| $86.7M | 0.04% |
2,450,286
+780,099
|
|
||
291
Teva Pharmaceuticals
TEVA
$32.8B
| $86.6M | 0.04% |
5,164,890
-913,351
|
|
||
|
CNTA
292
Centessa Pharmaceuticals
CNTA
$4.23B
| $85.8M | 0.04% |
6,532,768
+610,282
|
|
||
293
Kirby Corp
KEX
$6.06B
| $85.4M | 0.04% |
753,078
+60,393
|
|
||
294
iShares Core International Aggregate Bond Fund
IAGG
$11.3B
| $83.6M | 0.04% |
1,635,834
-14,853
|
|
||
295
McDonald's
MCD
$221B
| $83.5M | 0.04% |
285,720
-674,029
|
|
||
296
Nova
NVMI
$9.98B
| $83.2M | 0.04% |
302,411
+78,698
|
|
||
297
Inspire Medical Systems
INSP
$4.08B
| $83.2M | 0.04% |
640,923
-1,837
|
|
||
298
Itron
ITRI
$4.33B
| $83M | 0.04% |
630,305
+81,024
|
|
||
299
Wintrust Financial
WTFC
$9.12B
| $82.4M | 0.04% |
664,240
+11,510
|
|
||
300
Disc Medicine
IRON
$3.46B
| $82.3M | 0.04% |
1,553,961
+130,702
|
|